Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 404 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR ‘Will cancer make me infertile?’ – That Cancer Conversation May 12, 2021 EMA Recommends Granting a Conditional Marketing Authorisation for Epcoritamab August 17, 2023 FDA Approves Talazoparib with Enzalutamide for HRR Gene-Mutated Metastatic Castration-Resistant Prostate... July 6, 2023 Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard... May 13, 2019 Load more HOT NEWS FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for... New on NCI’s Websites for September 2021 Higher Rates of Metastasis-Free Survival in Men with High-Risk Non-Metastatic Prostate... FDA Approvals Expand Initial Treatment Options for Multiple Myeloma
